J. Goldman & Co LP - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 53 filers reported holding AGILE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$6,000
+50.0%
10,4200.0%0.00%
Q3 2018$4,000
-55.6%
10,420
-42.1%
0.00%
Q2 2018$9,000
-99.4%
18,000
-96.9%
0.00%
-100.0%
Q1 2018$1,500,000
+631.7%
583,633
+1521.2%
0.06%
+357.1%
Q4 2016$205,000
-84.1%
36,000
-80.5%
0.01%
-80.8%
Q3 2016$1,291,000
-34.0%
184,977
-28.0%
0.07%
-28.4%
Q2 2016$1,956,000
+1.5%
256,980
-17.2%
0.10%
-15.0%
Q1 2016$1,928,000310,4320.12%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Perceptive Advisors 15,919,925$15,301,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 735,000$706,0000.09%
INVESTOR AB 3,510,189$3,370,0000.09%
GSA CAPITAL PARTNERS LLP 586,491$564,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 335,735$322,0000.05%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 70,000$67,0000.02%
Summit Global Investments 126,000$121,0000.01%
Ergoteles LLC 211,611$203,0000.01%
Centric Wealth Management 10,000$10,0000.00%
GRIMES & COMPANY, INC. 99,744$96,0000.00%
View complete list of AGILE THERAPEUTICS INC shareholders